Диссертация (1140306), страница 31
Текст из файла (страница 31)
Partnership between platelet-rich plasma andmesenchymal stem cells: in vitro experience // Muscles Ligaments Tendons J. ‒2014. ‒ Vol. 4, № 1. ‒ P. 52-62.399.Rutgers M., Saris D.B., Yang K.G. et al. Joint injury and osteoarthritis: solublemediators in the course and treatment of cartilage pathology // Immunotherapy.‒ 2009.
‒ Vol. 1, № 3. ‒ P. 435-445.400.Sampson S., Reed M., Silvers H. et al. Injection of platelet-rich plasma inpatients with primary and secondary knee osteoarthritis: a pilot study // Am JPhys Med Rehabil. ‒ 2010. ‒ Vol. 89, № 12. ‒ P. 961-969.401.Sanchez M., Anitua E., Azofra J. et al. Intra-articular injection of anautologous preparation rich in growth factors for the treatment of knee OA: aretrospective cohort study // Clin Exp Rheumatol.
‒ 2008. ‒ Vol. 26, № 5. ‒ P.910913.402.Sanchez M., Fiz N., Azofra J. et al. A randomized clinical trial evaluatingplasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in theshort-term treatment of symptomatic knee osteoarthritis // Arthroscopy. ‒ 2012.‒ Vol. 28, № 8. ‒ P.
1070-1078.403.Sanchez M., Guadilla J., Fiz N. et al. Ultrasound-guided platelet-rich plasmainjections for the treatment of osteoarthritis of the hip // Rheumatology(Oxford). ‒ 2012. ‒ Vol. 51, № 1. ‒ P. 144-150.404.Sawitzke A.D., Shi H., Finco M.F., et al. The effect of glucosamine and/orchondroitin sulfate on the progression of knee osteoarthritis: a report from theglucosamine/chondroitin arthritis intervention trial.//Arthritis Rheum. – 2008; 58:3183–91.405.Say F., Gurler D., Yener K. et al. Platelet-rich plasma injection is moreeffective than hyaluronic acid in the treatment of knee osteoarthritis // Acta ChirOrthop Traumatol Cech. ‒ 2013.
‒ Vol. 80, № 4. ‒ P. 278-283.406.Schiphof D., Boers M., Differences in descriptions of Kellgren and Lawrencegrades of knee osteoarthritis. // Ann. Rheum. Dis. – 2008; 67: 1034–6.197407.Serra C.I., Soler C., Carillo J.M. Effect of autologous platelet-rich plasma onthe repair of full-thickness articular defects in rabbits // Knee Surg.SportsTraumatol. Arthrosc.
– 2013 – 21(8) h.1730-1736.408.Serraino GF, Dominijanni A, Jiritano F, et al. Platelet-rich plasma inside thesternotomy wound reduces the incidence of sternal wound infections. IntWound J 2015; 12:260-4.409.Shen l., Yuan T., Chen S. et al. The temporal effect of platelet-rich plasma onpain and physical function in the treatment of knee osteoarthritis: systematicreview and meta-analysis of randomized controlled trials // J. Orthop.Surg.Res.– 2017 – 23 – 12(1) – p.16.410.Sheth U., Simunovic N., Klein G. et al. Efficacy of autologous platelet-richplasma use for orthopedic indications: a meta-analysis // J Bone Joint Surg Am.‒ 2012.
‒ Vol. 94, № 4. ‒ P. 298-307.411.Singh G, Fort JG, Goldstein JL et al for the SUCCESS-I Investigators.Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESSI study. Am J Med. 2006; 119:255-66412.Singh G, Lanes S, Triadafilopoulos G. Risk of serious upper gastrointestinaland cardiovascular thromboembolic complications with Meloxicam. TheAmerican Journal of Medicine, 2004, 100-6.413.Sinusas K. Osteoarthritis: diagnosis and treatment.
//Am. Fam. Physician. –2012; 85 (1): 49–56.414.Smyth N.A., Murawski C.D., Fortier L.A. et al. Platelet-rich plasma in thepathologic processes of cartilage: review of basic science evidence //Arthroscopy. – 2013. – Vol. 29. – P.1399–1409.415.Song K.H, Yoon D.K., Bae S.J. Cartilage healing after microfracture inosteoarthritic knees // Arthroscopy. 2006. - № 22(4). - P. 367-374.416.Spakova T., Rosocha J., Lacko M.
et al. Treatment of knee joint osteoarthritiswith autologous platelet-rich plasma in comparison with hyaluronic acid // AmJ Phys Med Rehabil. ‒ 2012. ‒ Vol. 91, № 5. ‒ P. 411-417.198417.Stanton, P.T. Kijowski R., Blankenbaker D.G. Radiographic findings ofosteoarthritis versus arthroscopic findings of articular cartilage degeneration inthe tibiofemoral joint // Radiology. 2007. - № 249(1). -P.807-814.418.Steadman, J.R. et al.
Outcomes of microfracture for traumatic chondral defects ofthe knee: average 11-year follow-up // Arthroscopy 2003. Vol. 19, N 5. - P. 477484.419.Sun Y., Feng Y., Zhang C.Q. et al. The regenerative effect of platelet-richplasma on healing in large osteochondral defects // Int Orthop. ‒ 2010. ‒ Vol.34, № 4. ‒ P. 589-97.420.Sundman E.A., Cole B.J., Fortier L.A.
Growth factor and catabolic cytokineconcentrations are influenced by the cellular composition of platelet-richplasma // Am J Sports Med. ‒ 2011. ‒ Vol. 39, № 10. ‒ P. 2135-2140.421.Sundman E.A., Cole B.J., Karas V. et al. The anti-inflammatory and matrixrestorative mechanisms of platelet-rich plasma in osteoarthritis // Am J SportsMed. ‒ 2014. ‒ Vol.
42, № 1. ‒ P. 35-41.422.Taylor D.W., Petrera M., Hendry M. et al. A systematic review of the use ofplatelet-rich plasma in sports medicine as a new treatment for tendon andligament injuries // Clin J Sport Med. ‒ 2011. ‒ Vol. 21, № 4. ‒ P. 344-352.423.Tegner Y Rating system in evaluation of knee ligament injuries / Y Tegner, J.Lysholm // Clinical orthopaedics and related research, 1985. Vol. 198. - P. 43-49424.Textor J. Platelet-Rich Plasma (PRP) as a Therapeutic Agent: Platelet Biology,Growth Factors and a Review of the Literature. In: Lana JF (ed), Platelet-RichPlasma, Platelet-Rich Plasma Regenerative Medicine: Sports Medicine,Orthopedic, and Recovery of Musculoskeletal Injuries, Springer. 2014; 61-81.DOI: 10.1007/978-3-642-40117-6.425.Tietze D.C., Geissler K., Borchers J. The effects of platelet-rich plasma in thetreatment of large-joint osteoarthritis: a systematic review // Phys Sportsmed.
‒2014. ‒ Vol. 42, № 2. ‒ P. 27-37.426.Thon J.N., Italiano J.E. Platelets: production, morphology and ultrastructure //Handb Exp Pharmacol. ‒ 2012. ‒ № 210. ‒ P. 3-22.199427.Thorlund J.B., Hare K.B., Lohmander L.S. Large increase in arthroscopicmeniscus surgery in the middle-aged and older population in Denmark from2000 to 2011. // Acta Orthop. – 2014; 85: 287–92.428.Tohidnezhad M., Varoga D., Wruck C.J.
et al. Platelets display potentantimicrobial activity and release human beta-defensin 2 // Platelets. ‒ 2012. ‒Vol. 23, № 3. ‒ P. 217-223.429.Towheed TE, Maxwell L, Anastassiades TP, Shea B et al. Glucosaminetherapy for treating osteoarthritis. The Cochrane Database reviews 2005, Issue2.430.Trickey T.R., Lee M., Guilak T. Viscoelastic properties of chondrocytes fromnormal and osteoarthritic human cartilage // J.Orthop. Res - 2000 -№ 18-P 891898431.Trifonova E., Sazonova O., Zonova E. The Association between ClinicalSymptoms and Serum Cytokines Levels in Patients with Knee Osteoarthritisand Comorbidity //Annals of the Rheumatic Diseases. – 2016.
– Т. 75. – №.Suppl 2. – P. 1162-1162.432.van Buul G.M., Koevoet W.L., Kops N. et al. Platelet-rich plasma releasateinhibits inflammatory processes in osteoarthritic chondrocytes // Am J SportsMed. ‒ 2011. ‒ Vol. 39, № 11. ‒ P. 2362-2370.433.van den Berg W.B. Osteoarthritis year 2010 in review: pathomechanisms //Osteoarthritis Cartilage. ‒ 2011.
‒ Vol. 19, № 4. ‒ P. 338-341.434.van der Kraan P.M., Goumans M.J., Blaney Davidson E. et al. Age dependentalteration of TGF-beta signaling in osteoarthritis // Cell Tissue Res. ‒ 2012. ‒Vol. 347, № 1. ‒ P. 257-265.435.Vaquerizo V., Plasencia M.A., Arribas I. et al. Comparison of intraarticularinjections of plasma rich in growth factors (PRGF-Endoret) versus Durolanehyaluronic acid in the treatment of patients with symptomatic osteoarthritis: arandomized controlled trial // Arthroscopy.
‒ 2013. ‒ Vol. 29, № 10. ‒ P. 16351643.200436.Vignon E., Valat J.P., Rossignol M., et al. Osteoarthritis of the knee and hipand activity: a systematic international review and synthesis (OASIS). // JointBone Spine. – 2006; 73: 442–55.437.Wandel S., Jüni P., Tendal B., et al. Effects of glucosamine, chondroitin, orplacebo in patients with osteoarthritis of hip or knee: network meta-analysis. //BMJ.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
